We are live on
!
Find out more
VAIA
Virtus Alternative Investment Advisers Portfolio holdings
AUM
$6.71M
1-Year Est. Return
36.98%
This Fund
S&P 500
This Quarter
Est. Return
+15.08%
1 Year Est. Return
+36.98%
3 Year Est. Return
+42.83%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.71M
AUM Growth
+$1.27M
(+23%)
Cap. Flow
+$345K
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
47.64%
Holding
286
New
20
Increased
6
Reduced
248
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DGL
Invesco DB Gold Fund
DGL
|
+$1.63M |
| 2 |
Charter Communications
CHTR
|
+$148K |
| 3 |
Comcast
CMCSA
|
+$146K |
| 4 |
Delta Air Lines
DAL
|
+$99.8K |
| 5 |
McDonald's
MCD
|
+$90.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Watsco Inc
WSO
|
+$101K |
| 2 |
Micron Technology
MU
|
+$87K |
| 3 |
Merck
MRK
|
+$66K |
| 4 |
Qualcomm
QCOM
|
+$50.6K |
| 5 |
Broadcom
AVGO
|
+$48K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.11% |
| 2 | Technology | 14.44% |
| 3 | Communication Services | 14.32% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
C.H. Robinson
CHRW
$22B
| $5K | 0.07% |
55
-53
| -49% | -$5.06K |
|
252
Clorox
CLX
$11.6B
| $5K | 0.07% |
26
-26
| -50% | -$5.38K |
|
253
CryoPort
CYRX
$775M
| $5K | 0.07% |
123
-119
| -49% | -$5.67K |
|
254
Enanta Pharmaceuticals
ENTA
$372M
| $5K | 0.07% |
126
-122
| -49% | -$5.37K |
|
255
Flowers Foods
FLO
$1.64B
| $5K | 0.07% |
239
-231
| -49% | -$5.38K |
|
256
Fastly Inc
FSLY
$3.17B
| $5K | 0.07% |
60
-57
| -49% | -$5.03K |
|
257
Hormel Foods
HRL
$13.9B
| $5K | 0.07% |
115
-112
| -49% | -$5.46K |
|
258
OrthoPediatrics
KIDS
$485M
| $5K | 0.07% |
132
-127
| -49% | -$5.82K |
|
259
Madrigal Pharmaceuticals
MDGL
$12.6B
| $5K | 0.07% |
45
-44
| -49% | -$5.38K |
|
260
Vail Resorts
MTN
$5.19B
| $5K | 0.07% |
+18
| New | +$4.65K |
|
261
Neurocrine Biosciences
NBIX
$17.7B
| $5K | 0.07% |
56
-55
| -50% | -$5.31K |
|
262
NovaGold Resources
NG
$2.6B
| $5K | 0.07% |
496
-479
| -49% | -$5.06K |
|
263
Penumbra
PEN
$12.5B
| $5K | 0.07% |
28
-26
| -48% | -$5.7K |
|
264
Royal Gold
RGLD
$17.1B
| $5K | 0.07% |
46
-44
| -49% | -$5.08K |
|
265
Relmada Therapeutics
RLMD
$544M
| $5K | 0.07% |
150
-145
| -49% | -$4.98K |
|
266
Schneider National
SNDR
$6.59B
| $5K | 0.07% |
224
-217
| -49% | -$4.85K |
|
267
Tandem Diabetes Care
TNDM
$1.17B
| $5K | 0.07% |
52
-50
| -49% | -$5.15K |
|
268
Viking Therapeutics
VKTX
$4.04B
| $5K | 0.07% |
843
-814
| -49% | -$4.93K |
|
269
Wingstop
WING
$3.68B
| $5K | 0.07% |
39
-179
| -82% | -$23.4K |
|
|
SILK
270
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $5K | 0.07% |
81
-79
| -49% | -$4.9K |
|
|
SGEN
271
DELISTED
Seagen Inc. Common Stock
SGEN
| $5K | 0.07% |
31
-30
| -49% | -$5.59K |
|
|
GBT
272
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5K | 0.07% |
105
-101
| -49% | -$4.98K |
|
|
CTXS
273
DELISTED
Citrix Systems Inc
CTXS
| $5K | 0.07% |
41
-40
| -49% | -$5.09K |
|
|
LMNX
274
DELISTED
Luminex Corp
LMNX
| $5K | 0.07% |
228
-220
| -49% | -$5.11K |
|
275
Allogene Therapeutics
ALLO
$601M
| $4K | 0.06% |
156
-151
| -49% | -$4.92K |
|
Similar funds
SAM
AIDCT
FPC
RC
NCM
GBA
GFWEX
HAM
Virtus Alternative Investment Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, Virtus Alternative Investment Advisers held 286 positions worth $6.71M, up 23% from $5.44M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Virtus Alternative Investment Advisers deployed $345K of net new capital in Q4 2020, opening 20 new positions and adding to 6 existing holdings. Its largest new stake was Invesco DB Gold Fund: 29,703 shares worth $1.64M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Watsco Inc, an estimated $101K trimmed.
- Virtus Alternative Investment Advisers's largest Q4 2020 buy was Invesco DB Gold Fund: 29,703 shares worth $1.64M.
- Virtus Alternative Investment Advisers added most to Charter Communications in Q4 2020, an estimated $148K increase.
- Virtus Alternative Investment Advisers's biggest Q4 2020 reduction was Watsco Inc, cutting an estimated $101K.
- Virtus Alternative Investment Advisers fully exited Merck in Q4 2020, selling an estimated $66K.
- Virtus Alternative Investment Advisers's ten largest holdings make up 48% of its $6.71M portfolio in Q4 2020.
- Virtus Alternative Investment Advisers opened 20 new positions and closed 6 in Q4 2020.
- Virtus Alternative Investment Advisers's portfolio value rose 23% quarter-over-quarter to $6.71M.
Based on Virtus Alternative Investment Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.